Literature DB >> 3557906

Muromonab-CD3 (Orthoclone OKT3): the first monoclonal antibody approved for therapeutic use.

C Emmons, L G Hunsicker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3557906

Source DB:  PubMed          Journal:  Iowa Med        ISSN： 0746-8709


× No keyword cloud information.
  15 in total

1.  Optimal Affinity of a Monoclonal Antibody: Guiding Principles Using Mechanistic Modeling.

Authors:  Abhinav Tiwari; Anson K Abraham; John M Harrold; Anup Zutshi; Pratap Singh
Journal:  AAPS J       Date:  2016-12-21       Impact factor: 4.009

2.  CPP Applications in Immune Modulation and Disease Therapy.

Authors:  Ja-Hyun Koo; Won-Ju Kim; Je-Min Choi
Journal:  Methods Mol Biol       Date:  2022

Review 3.  Designing Human Antibodies by Phage Display.

Authors:  André Frenzel; Jonas Kügler; Saskia Helmsing; Doris Meier; Thomas Schirrmann; Michael Hust; Stefan Dübel
Journal:  Transfus Med Hemother       Date:  2017-08-25       Impact factor: 3.747

Review 4.  Challenges in Antibody Development against Tn and Sialyl-Tn Antigens.

Authors:  Liliana R Loureiro; Mylène A Carrascal; Ana Barbas; José S Ramalho; Carlos Novo; Philippe Delannoy; Paula A Videira
Journal:  Biomolecules       Date:  2015-08-11

5.  Monoclonal antibody humanness score and its applications.

Authors:  Sean H Gao; Kexin Huang; Hua Tu; Adam S Adler
Journal:  BMC Biotechnol       Date:  2013-07-05       Impact factor: 2.563

Review 6.  Phage display-derived human antibodies in clinical development and therapy.

Authors:  André Frenzel; Thomas Schirrmann; Michael Hust
Journal:  MAbs       Date:  2016-07-14       Impact factor: 5.857

7.  Natural and non-natural amino-acid side-chain substitutions: affinity and diffraction studies of meditope-Fab complexes.

Authors:  Krzysztof P Bzymek; Kendra A Avery; Yuelong Ma; David A Horne; John C Williams
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2016-10-24       Impact factor: 1.056

8.  "Magic Bullets" at the center stage of immune therapy: a special issue on therapeutic antibodies.

Authors:  Zhiqiang An
Journal:  Protein Cell       Date:  2018-01       Impact factor: 14.870

9.  Targeting Human-Cytomegalovirus-Infected Cells by Redirecting T Cells Using an Anti-CD3/Anti-Glycoprotein B Bispecific Antibody.

Authors:  Weixu Meng; Aimin Tang; Xiaohua Ye; Xun Gui; Leike Li; Xuejun Fan; Robbie D Schultz; Daniel C Freed; Sha Ha; Dai Wang; Ningyan Zhang; Tong-Ming Fu; Zhiqiang An
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

Review 10.  Therapeutic antibodies: their mechanisms of action and the pathological findings they induce in toxicity studies.

Authors:  Masami Suzuki; Chie Kato; Atsuhiko Kato
Journal:  J Toxicol Pathol       Date:  2015-06-15       Impact factor: 1.628
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.